68
Pharmosa Biopharm Inc.
6875.TWO · TWO
$32.80 -0.61% (-$0.20)
1M +0.76%
Market Cap $4.24B
P/E Ratio -
Div. Yield -
ROE 23.20%
Piotroski F-Score Weak
1/9Valuation
33 /100
Expensive P/S 79.38x
P/B 3.10x
P/E N/A
Growth
100 /100
Growing Book val. growth 26.97%
EPS growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 37.35%
Net margin 658.14%
Op. margin 762.03%
Quality
0 /100
Poor ROIC 23.64%
ROE 23.20%
ROA 19.71%
Debt
69 /100
Low Debt/Equity 0.25x
Current ratio 12.45x
Int. coverage -148.64x
Stability
1 /100
Unstable Beta 0.19x
EPS volatility 1,078.95%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6875.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Pei Kan
Employees
15
Headquarters
Taipei City